Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

425 ARTÍCULOS , VIENDO DEL 286 AL 300

Lecanemab appropriate use recommendations for clinical practice in the UK

Mummery CJ, Rasmussen J, Blackburn D, Coulthard E, Davies RR, Dorsey R, Fox NC, Hosseini AA, Ivenso C, Jones M, Kennelly SP, Kipps C, Lashley D, Mackay G, Negi R, Nilforooshan R, Passmore PA, Perry R, Raymont V, Rowe JB, Russ TC, Taylor JP, Burns A.

J Neurol Neurosurg Psychiatry. 2026 Apr 15;97(5):372-384. doi: 10.1136/jnnp-2025-336597.

[Alzheimer's disease and bilingualism]

Syromyatnikov NN, Preobrazhenskaya IS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(4. Vyp. 2):40-46. doi: 10.17116/jnevro202612604240.

The interventional effect of acupuncture on overall cognitive function in Alzheimer's disease spectrum disorders: A meta-analysis

Chen Y, Zhao S, Yang F, Wang Y, Han Z, Han F, Wang Z, Chen Z, Sun K, Liang P, Li K.

J Alzheimers Dis. 2026 Jun;111(3):959-978. doi: 10.1177/13872877261438495. Epub 2026 Apr 8.

Alzheimer and cardiovascular genetic scores and cognition: the FINGER randomized controlled trial

Saadmaan G, Dalmasso MC, Maria M, Lehtisalo J, Hiltunen M, Kaikkonen MU, Levälahti E, Mangialasche F, Perola M, Ramirez A, Stephen R, Ngandu T, Kivipelto M, Solomon A.

Brain. 2026 Feb 7;149(2):644-652. doi: 10.1093/brain/awaf277.

Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial

Devanand DP, Wisniewski T, Razlighi Q, Qian M, Wei R, Andrews HF, Acosta EP, Bell KL, Pelton GH, Deliyannides D, Perrin AC, Caccappolo E, Gershon AA, Prasad KM, Kreisl WC, Mintz A, Huey ED.

JAMA. 2026 Feb 10;335(6):511-522. doi: 10.1001/jama.2025.21738.

Leading by example: How the Webster team's systematic review quietly rebuked the field's preoccupation with biomarker "disclosure," and why it matters

Lingler JH.

J Alzheimers Dis. 2026 Mar;110(1):86-88. doi: 10.1177/13872877251412917. Epub 2026 Feb 13.

Screening for Alzheimer's disease in the community using an AI-driven screening platform: design of the PREDICTOM study

Brem AK, Khan Z, Radermacher J, Georgiadis K, Lazarou I, Grammatikopoulou M, Pickering E, Mitterreiter J, Aakre JA, Ashton NJ, Baquero M, Beser-Robles M, Braboszcz C, Brandt S, Brown J, Cacciamani F, Campill S, Collins C, Deshpande P, Diaz A, Durrleman S, Engelborghs S, Ferré-González L, Frisoni GB, Gjestsen MT, Gove D, Honigberg L, Huang B, Hudak A, Kaushik S, Letoha T, Marquardt G, Mendes AJ, Müllenborn M, Paletta L, de Barros NP, Pszeida M, Vik-Mo AO, Rostamipour H, Perneczky R, Rauchmann BS, Russegger S, Schirmer T, Shadmaan A, Solana AB, Soria-Frisch A, Tegethoff P, Ribbens A, De Witte S, van der Giezen M, Nikolopoulos S, Corbett A, Fröhlich H, Aarsland D; PREDICTOM Consortium.

J Prev Alzheimers Dis. 2026 May;13(5):100545. doi: 10.1016/j.tjpad.2026.100545. Epub 2026 Mar 26.

The Alzheimer's Pathways Sleep Study (ALPS): an experimental randomized controlled trial to improve cognition and Alzheimer's pathophysiology through slow-wave sleep

Dong YC, Habte RF, Dessa KM, Fletcher ME, Ianni AM, Lopresti BJ, Aizenstein HJ, Cohen AD, Karikari TK, Weinstein AM, Gebara MA, Wallace ML, Buysse DJ, Wilckens KA.

Trials. 2026 Feb 19;27(1):237. doi: 10.1186/s13063-026-09505-w.

What Does a Positive Alzheimer Disease Blood-Based Biomarker Result Mean in People With Mild Cognitive Impairment?

Hazan J, Liu KY, Isaacs JD, Fox NC, Howard R.

Neurology. 2026 May 26;106(10):e214953. doi: 10.1212/WNL.0000000000214953. Epub 2026 May 4.

Redefining management of mild cognitive impairment and Alzheimer's disease through the shift from clinical to clinical-biological diagnosis: Insights from a single-center experience

Giuffrè GM, Battisti F, Tudor AM, Lenkowicz J, Avitabile A, Rosati AM, Martellacci N, Patarnello S, Torelli F, Cesario A, Marra C.

J Alzheimers Dis. 2026 Feb;109(4):1945-1954. doi: 10.1177/13872877251411461. Epub 2026 Jan 5.

Longitudinal subcortical volume changes and their correlations with multiple PET and fluid biomarkers in dominantly inherited Alzheimer's disease

Choo IH, Park H, Gordon BA, Bateman RJ; Dominantly Inherited Alzheimer Network.

J Prev Alzheimers Dis. 2026 Apr;13(4):100513. doi: 10.1016/j.tjpad.2026.100513. Epub 2026 Feb 27.

Serum Expression of miR-106b-3p and Its Diagnostic Significance in Alzheimer Disease

Hou D, Hou Z, Qu H, Sun M, Wang L.

Alzheimer Dis Assoc Disord. 2026 Jan-Mar 01;40(1):23-29. doi: 10.1097/WAD.0000000000000710. Epub 2026 Feb 17.

Sleep architecture and self-reported sleep quality are associated with Alzheimer's disease biomarkers in older adults without dementia

Liu S, Huang J, Calderon R, Spira AP, Mcphillips MV, Gooneratne N, Gill J, Li J.

J Gerontol A Biol Sci Med Sci. 2026 May 7;81(6):glag081. doi: 10.1093/gerona/glag081.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias